QURE
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Ptc Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get PTCT alertsKylie O'Keefe has spoken on 5 earnings calls across 2 companies, most recently for uniQure N.V. on November 4, 2026. Those appearances were for uniQure N.V. (QURE) and Ptc Therapeutics, Inc. (PTCT). uniQure N.V. is classified in the Biotechnology industry within the Healthcare sector. Ptc Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at uniQure N.V. includes Matthew Kapusta (CEO and Board Member), Philip Astley-Sparke (Chairman) and Christian Klemt (CFO and Chief Accounting Officer).
“With a known PDUFA date ahead of us, the question for our customer-facing team is no longer when. It's how. How do we make sure every piece of this patient journey is in place and well supported by the PDU4D8?”
“I want to begin, as always, by acknowledging the Huntington's disease community, the patients, the families, and the caregivers who live with this disease every day. the clinicians who care for them, and the advocates who have tirelessly pushed for regulatory flexibility and access.”
“To the Huntington's disease patient community, we want to thank you for your extraordinary strength, resilience, and unwavering commitment to advancing disease-modifying therapies for HD.”
“And thank you for joining us today to discuss the PTC Therapeutics third quarter 2021 corporate update and financial results.”
“Good afternoon, and thank you for joining us to discuss PTC Therapeutics' fourth quarter and year end 2020 corporate update and financial results.”
Source not stated
Source not stated
QURE
Biotechnology · Healthcare
Biotechnology · Healthcare